Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Tai‐Jan Chiu"'
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Recent randomized phase III trials have demonstrated the efficacy of anti-programmed cell death 1 (PD-1) immune checkpoint inhibitors (ICIs) in treating patients with recurrent or metastatic head and neck squamous cell carcinoma (
Externí odkaz:
https://doaj.org/article/f988f4983f7144a0a33f3a42e9f1d4c9
Autor:
Yung-Yeh Su, Nai-Jung Chiang, Tai-Jan Chiu, Chien-Jui Huang, Shao-Jung Hsu, Hsin-Chen Lin, Shih-Hung Yang, Youngsen Yang, Wen-Chi Chou, Yen-Yang Chen, Li-Yuan Bai, Chung-Pin Li, Jen-Shi Chen
Publikováno v:
Biomedical Journal, Vol 47, Iss 3, Pp 100696- (2024)
Pancreatic cancer is a highly aggressive malignancy with a poor prognosis. Over the past decade, significant therapeutic advancements have improved the survival rates of patients with pancreatic cancer. One of the primary factors contributing to thes
Externí odkaz:
https://doaj.org/article/0a9533e767134d5d98383e9f10da7d50
Publikováno v:
Cancer Cell International, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background Research studies have demonstrated that Midkine (MDK) can influence the expression and activity of Renin-angiotensin system (RAS) components. Angiotensin II is involved in tumor growth and angiogenesis in different cancers. We pre
Externí odkaz:
https://doaj.org/article/c465c9ea60294deb93753382bede4535
Autor:
Tzu-Hsun Kao, Tai-Jan Chiu, Ching-Nung Wu, Shao-Chun Wu, Wei-Chih Chen, Yao-Hsu Yang, Yu-Ming Wang, Sheng-Dean Luo
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1480 (2024)
Concurrent chemoradiotherapy (CCRT) is the standard treatment for patients with locally advanced squamous cell carcinoma of the head and neck (HNSCC). Pneumonia is a significant complication in these patients. This study aims to identify pneumonia ri
Externí odkaz:
https://doaj.org/article/2fc33733520b4892a28f34c972da0d9a
Autor:
Yu-Ming Wang, Sheng-Dean Luo, Ching-Nung Wu, Shao-Chun Wu, Wei-Chih Chen, Yao-Hsu Yang, Tai-Jan Chiu
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 2946 (2023)
This study evaluated the clinical characteristics of head and neck cancer (HNC) patients with hepatitis B (HBV) or hepatitis C (HCV) who underwent concurrent chemoradiotherapy (CCRT) and examined the prognostic impact of antiviral therapies. In a 19-
Externí odkaz:
https://doaj.org/article/fd6e3f468a0e437c8f55943a66504b1e
Aberrant miR-874-3p/leptin/EGFR/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis
Autor:
Sheng-Dean Luo, Hsin-Ting Tsai, Chung-Feng Hwang, Tai‐Jan Chiu, Shau‐Hsuan Li, Ya-Ling Hsu, Chang-Chun Hsiao, Chang-Han Chen
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-20 (2022)
Abstract Background Leptin is important in physiological and pathological functions in various cancers, however, the significance and mechanisms of leptin in nasopharyngeal carcinoma remain ambiguous. Methods Leptin expression was analyzed by QPCR, i
Externí odkaz:
https://doaj.org/article/69f9f2cb852d42729675669d1c8a3ff0
Autor:
Sheng-Dean Luo, Shao-Chun Wu, Wei-Chih Chen, Ching-Nung Wu, Tai-Jan Chiu, Yao-Hsu Yang, Shau-Hsuan Li, Fu-Min Fang, Tai-Lin Huang, Chang-Chun Hsiao, Chang-Han Chen
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Oral squamous cell carcinoma (OSCC) remains one of the most challenging clinical problems in the field due to its high rate of locoregional and distant metastases. However, studies that assess the association between aspirin use and survival
Externí odkaz:
https://doaj.org/article/5402fd33797f41dea3bf84e48b122b74
Autor:
Chun-Yuan Chao, Sheng-Dean Luo, Wei-Chih Chen, Shao-Chun Wu, Tai-Jan Chiu, Yu-Ming Wang, Yao-Hsu Yang, Fu-Min Fang, Shau-Hsuan Li, Chung-Yi Li, Ching-Nung Wu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectivesFew studies have evaluated the impact of blood glucose levels on cancer prognosis. We investigated the association between hemoglobin A1c (HbA1c) and survival in oral squamous cell carcinoma (OSCC) patients.Materials and MethodsA 19-year re
Externí odkaz:
https://doaj.org/article/994bff195257450a925f1660c0648e1e
Autor:
Yung-Yeh Su, Nai-Jung Chiang, Chung-Pin Li, Chia-Jui Yen, Shih-Hung Yang, Wen-Chi Chou, Jen-Shi Chen, Tai-Jan Chiu, Yen-Yang Chen, Shih-Chang Chuang, Li-Yuan Bai, Chang-Fang Chiu, Cheng-Ming Peng, De-Chuan Chan, Sz-Chi Chiu, Yi-Hsin Yang, Yan-Shen Shan, Li‐Tzong Chen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionThis multicenter, real-world cohort study aimed to evaluate the effectiveness of early cumulative dose administration and dosing pattern of liposomal irinotecan plus fluorouracil/leucovorin (nal-IRI+5-FU/LV) in patients with gemcitabine-r
Externí odkaz:
https://doaj.org/article/ae5f896e6042415b809ccdd1fe10f236
Autor:
Tai-Jan Chiu, Yung-Yeh Su, Shih-Hung Yang, Chung-Pin Li, Li-Yuan Bai, Nai-Jung Chiang, Shih-Chang Chuang, Yan-Shen Shan, De-Chuan Chan, Li-Tzong Chen, Chia-Jui Yen, Cheng-Ming Peng, Yen-Yang Chen, Jen-Shi Chen, Wen-Chi Chou
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Liposomal irinotecan (nal-IRI) plus 5-fluorouracil and leucovorin (5-FU/LV) is currently the standard second-line treatment for patients with pancreatic ductal adenocarcinoma (PDAC) after previous failed gemcitabine-based therapy. This po
Externí odkaz:
https://doaj.org/article/4f0d6e13c91c49d18e9d3d1591cc40a2